Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 180 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

 		Non-small Cell Lung Cancer Phase1

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

 		Myeloid Diseases Phase1

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL

 		Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Phase1, Phase2

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

 		Mesothelioma Phase1

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

 		Retinopathy of Prematurity

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

 		Lupus Nephritis Phase2

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

 		Hidradenitis Suppurativa

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

 		Chronic Rhinosinusitis With Nasal Polyps

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

 		Asthma Phase3

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

 		Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Phase1